Picture of Cellid Co logo

299660 Cellid Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Cellid Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2,494-4,126-13,071-22,865-11,611
Depreciation
Amortisation
Non-Cash Items-376-1,1347178,847316
Unusual Items
Other Non-Cash Items
Changes in Working Capital8391,0041,860-7991,516
Change in Accounts Receivable
Change in Other Assets
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1,921-3,763-8,206-12,216-7,115
Capital Expenditures-4,284-11,715-3,112-1,203-11,284
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-32,82016,885-7,03215,20510,532
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-37,1035,170-10,14414,002-752
Financing Cash Flow Items1121097601,343746
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities39,81538720,0851,26312,993
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7911,7941,7353,0495,126